Table 1.

NVP resistance detected in plasma and breast milk samples (Uganda, 2003–2004)^*.

ID	Subtype	Plasma 4 weeks	Breast milk 4 weeks	Breast milk 10 weeks
64	D	K103N	WT
117	A	V106A	WT
52	D	G190A	WT
5	D	K103N+G190A	WT
79	D	Y181C+Y188C	WT
42	A	WT	G190A	WT
17	D	WT	Y188C	WT
8	A	WT	Y181C	Failed
69	A	WT	K103N	WT
39	D	Y181C	Y181C	WT
3	R	Y181C+Y188C	Y188C	K103N
23	D	K103N+Y181C	Y181C	WT
77	R	K103N+Y181C	K103N	WT
30	D	K103N+Y181C+Y188C	K103N+Y181C+Y188C	K103N+G190A
13	D	K103N+V106A+Y188C	K103N	No sample
24	C	K103N+Y181C+Y188C+G190A	K103N+Y181C+Y188C+G190A	K103N
22	A	K103N+V106A+Y181C+G190A	K103N+V106A+G190A	K103N

^*Thirteen women had no NVP resistance mutations detected in plasma or breast milk. Results are shown for the 17 women who had at least one NVP resistance mutation detected in either sample. R indicates inter-subtype recombinant; wild type (WT) indicates no resistance mutations detected.